SMARCA4 and neoplasm: Therefore, we further investigated the pathology of this tumor by investigating how ARID1A, which is part of the same BAF complex as SMARCA4, changes in SAMRCA4 deficient tumors and examined the expression of SLC11A, a downstream factor of ARID1A.